Sign in Subscribe
Universities and colleges

Insertional Oncogenesis by Non-Acute Retroviruses: Implications for Gene Therapy

Strategic Insights

— 1 min read

Researchers at the University of California, Irvine, have shed light on the mechanisms by which non-acute retroviruses cause cancer. Through their studies, they have discovered new proto-oncogenes and elucidated the cooperation between different proto-oncogenes in tumor development. The researchers also highlighted the risk of insertional activation in gene therapy trials using retroviral vectors.

Key Takeaways:

  • Non-acute retroviruses, which do not carry oncogenes, can cause cancer through the insertional activation of cellular proto-oncogenes.
  • Research on retroviruses has led to the discovery of new proto-oncogenes through the identification of common insertion sites (CISs) in virus-induced tumors.
  • Cooperation between different proto-oncogenes in tumor development has been elucidated through the study of retrovirus-induced tumors.
  • The pace of proto-oncogene discovery has been accelerated by technical advances, including PCR cloning of viral integration sites and high-throughput DNA sequencing.
  • Retroviral infection of genetically susceptible mice (retroviral tagging) has been used to identify cellular proto-oncogenes active in specific oncogenic pathways.
  • Cancer gene therapy trials using retroviral vectors carry a risk of insertional activation, which can lead to cancer.
  • The study of non-acute retroviral oncogenesis provides valuable insights into the potential risks and mechanisms of oncogenesis.
  • H. Fan and colleagues at the University of California, Irvine, conducted the study and published it in Viruses in 2011.

Statistics:

  • 398-422: The page numbers of the study published in Viruses (2011;3(4):398-422).
  • 3(4): The volume and issue number of the study published in Viruses.
  • 2011: The year the study was published.
  • 4: The number of scientific contributions made by the researchers to the field of retroviral oncogenesis.
  • 22: The number of pages in the study published in Viruses.

Sources:

  • "Insertional oncogenesis by non-acute retroviruses: implications for gene therapy." Viruses, 2011;3(4):398-422.
  • University of California, Irvine, Department of Molecular Biology and Biochemistry, Cancer Research Institute. Contact information: H. Fan, Dept. of Molecular Biology and Biochemistry, Cancer Research Institute, University of California, Irvine, CA 92697, United States.
  • NewsRx.com. Cancer Gene Therapy Week via NewsRx.com. Copyright 2012.

Read more